InvestorsHub Logo

awesomesound

05/25/17 10:17 PM

#56151 RE: happyglass #56149

They...They...They, They own this, they did that, what I don't see is any of this mattering, when you see your investment losing 5%-8% a week! And no they didn't execute everything, They announce these big plans a year ahead, to hype the stock, investor lose their minds, and buy 1000's of share, only to have CEO's and Partner shareholders cashing out millions at a time!!!

I called CGC's fall from grace a year and a half ago, when I told investors the Uplist was a bad Idea, Well just look at your share price now!!

But Truthfully, it's to bad that investors can throw in money like it's a poker game, and Bruce cashes in $400,000 for "personal expenses, company only cares about upper management, they count on the small investor to take the brunt of the SP crush!!

can't figure out why smart investors, don't understand this??

Dogger05

05/27/17 3:54 PM

#56208 RE: happyglass #56149

My lament over inventory is if inventory was so high (it is) why the lack of product? Other lps have inventory that more closely matched their sales. I have been financing commercial businesses for more than 20 years and everytime I encountered a company with inventory levels even twice their sales they either had cash flow issues or needed to inject capital (or spend their capital) to keep things afloat....I don't buy into growing weed u can't currently sell....and if u care to do any dd, go back to when inventory levels jumped significantly (aprox late 2015) and you will find it was pre DNA strains which were not the best (hence seeking dna's help). Ask your self where did this poor quality weed go? I think it was stashed in the vault as opposed to destroyed (ie written off). It's well known they had trouble growing quality weed in the early going....no gmp production platform currently in place which will only increase their operating cost once they are forced to adapt that level of production standard (it's demanded in the pharmaceutical space). So to sum up, questionable inventory, lack of required production standard to participate in pharmacy distribution, and a shotgun approach to business plan really turns me off